As of Friday, all that was known about the Missouri case was that the individual was infected with an H5 virus. The CDC was ...
In a historic first, a therapy developed by Summit Therapeutics beat Merck blockbuster Keytruda in late-stage lung cancer ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...
A person in Missouri who didn’t report any contact with animals has tested positive for H5 bird flu, the state’s Department ...
Laurie Glimcher stunned Boston’s medical world last September by orchestrating Dana-Farber Cancer Institute’s breakup with ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
We have each worked on childhood vaccination programs in both development and humanitarian emergency settings for more than ...
Voters deserve to know the answers to these questions, and moderators need to ask. Mary Giliberti is the chief public policy ...
PREVENT, its creators acknowledge, is an experiment. If it can retain accuracy in predicting heart disease risk without using ...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Anyway, we ...
Private equity firms are leading the buyout of R1 RCM, a major provider of billing and administrative services for hospitals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results